Medtronic is a global leader in medical technology dedicated to improving healthcare and transforming patient outcomes through innovation and collaboration. Through its technologies, the Coronary and Renal Denervation operating unit seeks to improve health for the one billion people living with high blood pressure globally, and the 315 million people living with coronary artery disease around the world.
